A patient-centered approach to dietary supplements for patients with chronic liver disease

The use of dietary supplements by patients with chronic liver disease is prevalent and rising. Despite the known risks of dietary supplements, including hepatotoxicity, adulteration, and contamination, patients with chronic liver disease often turn to dietary supplements to support their liver and/or overall health but are not necessarily empowered with the information or guidance from their liver practitioner to do so. This article provides practitioners with a framework for balancing the risks and benefits of dietary supplements in patients with chronic liver disease, offering examples of independent resources and certifications to use this framework in clinical practice. We offer 3 common clinical scenarios to highlight how the use of this framework can improve communication and decision-making in clinical practice. By adapting principles from Integrative Medicine, this article advocates for a patient-centered approach to dietary supplements in patients with chronic liver disease, encouraging open dialogue between clinicians and their patients to facilitate informed decision-making and personalized care.

Authors

Institutions

Publication Details

Journal
Hepatology Communications
Published
2024-10-24
DOI
https://doi.org/10.1097/hc9.0000000000000552
Citations
5
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
2.33

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A patient-centered approach to dietary supplements for patients with chronic liver disease

Melinda R. Ring, Anand Dhruva, Gloria Y. Yeh, Jennifer C. Lai
5 citations
Hepatology Communications
Drug-Induced Hepatotoxicity and Protection
2.33
article

A patient-centered approach to dietary supplements for patients with chronic liver disease

Melinda R. Ring, Anand Dhruva, Gloria Y. Yeh, Jennifer C. Lai
article en
5 citations

Abstract

The use of dietary supplements by patients with chronic liver disease is prevalent and rising. Despite the known risks of dietary supplements, including hepatotoxicity, adulteration, and contamination, patients with chronic liver disease often turn to dietary supplements to support their liver and/or overall health but are not necessarily empowered with the information or guidance from their liver practitioner to do so. This article provides practitioners with a framework for balancing the risks and benefits of dietary supplements in patients with chronic liver disease, offering examples of independent resources and certifications to use this framework in clinical practice. We offer 3 common clinical scenarios to highlight how the use of this framework can improve communication and decision-making in clinical practice. By adapting principles from Integrative Medicine, this article advocates for a patient-centered approach to dietary supplements in patients with chronic liver disease, encouraging open dialogue between clinicians and their patients to facilitate informed decision-making and personalized care.

Hepatology CommunicationsVol. 8(11)
Northwestern University (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), University of California, San Francisco (US), Berenson Allen Center for Noninvasive Brain Stimulation (US), UCSF Helen Diller Family Comprehensive Cancer Center (US)
National Institutes of Health
Peace, Justice and strong institutions
Openalex Percentile: Top 12%
Drug-Induced Hepatotoxicity and Protection
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A patient-centered approach to dietary supplements for patients with chronic liver disease — Melinda R. Ring, Anand Dhruva, et al. · Hepatology Communications (2024) | TGRS Research Map | TGRS